A March 6 NEJM study looked at a significant development in the management of recurrent bacterial vaginosis (BV) in women.
Historically, BV has been notoriously difficult to treat long-term, with high rates of recurrence in women. This study showed that treating male partners as part of the treatment strategy can have a significant impact.
The study found that when male partners of women with recurrent BV were treated with a combination of two drugs, the recurrence rate of BV was halved. Treating both partners simultaneously could reduce the chance of reinfection and lead to better long-term outcomes for women.